Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1592 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Multiple Self-healing Squamous Epithelioma | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81405, 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| MSSE | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Multiple self-healing squamous epithelioma (MSSE; MIM 132800), also known as Ferguson-Smith disease, is an autosomal dominant skin disorder caused by mutations in TGFBR1. While Loeys-Dietz syndrome (LDS1A; MIM609192) and thoracic aortic aneurysms (AAT5; MIM 608967) result from gain of function mutations in TGFBR1, MSSE appears to be due to a loss of function of the TGFBR1 gene. Reported mutations include missense changes in exon 2 within the extracellular ligand binding domain, nonsense changes, and frameshift changes. MSSE is characterized by multiple skin lesions that clinically and histologically resemble squamous carcinoma. These lesions grow rapidly for a few weeks starting as small papules and progressing into keratoacanthoma-like tumors with rolled edges and a central hyperkeratotic plug. After a few weeks, the tumors spontaneously regress leaving pitted scars. In MSSE, the TGFBR1 gene appears to act as a tumor suppressor requiring a second somatic hit to produce the lesions, resulting in incomplete penetrance and highly variable age of onset. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| TGFBR1 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 132800 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Hair and Nail disorders, Skin, Tooth | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.